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A B S T R A C T
Biosynthetic pathways play a fundamental role in the building and operation of the cell by synthesizing the constituents by which the cell is constructed, and by
producing signalling intermediates that play a key role in cell regulation. While a lot is known about the metabolite proﬁle of the cells and about the biochemical
pathways through which these metabolites are produced, the cellular localization of the biosynthetic machineries and the importance of this localization to the
regulation of the metabolism has often been given less attention. This derives from the fact that, for several of these pathways, the enzymes involved are found
colocalized in one compartment where their speciﬁc localization is unlikely to inﬂuence their function. The sphingolipid (SL) metabolic pathway is a notable
exception to this as SL synthetic enzymes are laid out on a speciﬁc pattern across the secretory compartments. Such compartmentalized organization of the SL
synthesis has functional implications as it makes the ﬁne-tuned regulation of the process possible by allowing cells to regulate speciﬁc segments of the pathway in
response to stimuli and for adaptation. The organization, dynamics, and regulation of the SLs and their biosynthetic machinery have been investigated using imaging-
based methods. Here we provide a brief introduction to the techniques that have been or that could be employed to visualize the SL biosynthetic machinery and SLs
themselves and discuss the insights provided by these studies in understanding this metabolism.
1. Introduction
The plasma membrane of eukaryotic cells is enriched in sphingoli-
pids (SLs), which serve both signalling and structural functions that are
fundamental for cell organization and physiology (Hannun and Obeid,
2018). The production of SLs begins in the Endoplasmic Reticulum (ER)
and continues at the Golgi complex with consecutive synthetic reactions
being distributed along the diﬀerent sub-compartments of the secretory
pathway. Thanks to this organization, enzymes are restricted to speciﬁc
compartments that provide them optimal physico-chemical conditions
for their activities and segregate them from competing enzymes. The
organelles hosting the SL synthetic enzymes, then, exchange metabolic
intermediates through vesicular and non-vesicular means and SL traf-
ﬁcking inﬂuences metabolic fate of SL precursors. Given the importance
of compartmentalization and traﬃcking for SL biosynthesis, we analyse
the published data on the subcellular distribution of SLs, SL biosyn-
thetic enzymes and of their regulators and the implications of the dis-
tinct localization to their function.
2. The SL biosynthetic pathway
The SL biosynthesis starts with the production of ceramide (Cer)
that is then channelled across multiple mutually exclusive pathways
(Fig. 1) ending up in hundreds of end products (Fig.1b) [see (Hannun
and Obeid, 2018; Yamaji and Hanada, 2015) for detailed descriptions].
Cer biosynthesis starts with the action of serine palmitoyl transferases
(SPT1-3) that condense the amino acid serine with palmitoyl CoA to
produce 3-ketodihydrosphingosine. This is then reduced by 3-ketodi-
hydrosphingosine reductase (KSR) to produce dihydrosphingosine
(a.k.a. sphinganine). Dihydrosphingosine is then acylated by one of the
six ceramide synthases (CerS1-6) using acyl CoA as the donor to pro-
duce dihydroceramide. The dihydroceramide thus produced is then
desaturated by the dihydroceramide–D4-desaturases (DES1 and DES2)
to produce Cer.
This Cer is processed along the secretory pathway and can meet
with one of the following anabolic fates: a. it can be transported by
CERT (ceramide transfer protein) in non-vesicular manner to sphingo-
myelin synthase (SMS) containing compartment, where a phos-
phocholine group is transferred from phosphtidylcholine to Cer to
produce sphingomyelin (SM); b. galactosyl transferase can add ga-
lactose to Cer to produce galactosylceramide (GalCer); c. similarly, a
glucosyl transferase can produce glucosylceramide (GlcCer); d. acyla-
tion of ceramide leads to the production of acylceramide which is then
accumulated in lipid droplets and e. ﬁnally phosphorylation of Cer
leads to the production of Cer-1-phosphate, an important mediator of
inﬂammatory signalling.
While SM is not modiﬁed any further, GalCer and GlcCer are further
modiﬁed to produce complex glycosphingolipids (GSLs). GalCer is
sulphated by cerebroside sulfotransferase to produce sulfatide, ga-
lactosylated to produce Gb2 or sialylated to produce GM4. GlcCer on
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the other hand is galactosylated to produce lactosylceramide (LacCer)
by lactosylceramide synthase (LCS). LacCer has multiple fates and is
further glycosylated to produce one of the following three series of
GSLs: a. Lacto/neolacto series initiated by the N-acetylglucosaminyl
transferase B3GNT5 (a.k.a. Lc3 synthase; Lc3S) that produces Lc3 b.
Globosides initiated by the galactosyl transferase A4GALT (a.k.a. Gb3
synthase; Gb3S) that produces Gb3 from LacCer and c. Ganglioseries
initiated by the sialyltransferase ST3GAL5 (a.k.a. GM3 synthase; GM3S)
that produces GM3. These GSLs are then processed by additional gly-
cosyltransferases to produce nearly 500 varieties of GSLs belonging to
the diﬀerent series (Fig. 1).
Individual tissues and cell types produce their own speciﬁc set of
SLs depending on the relative expression of SL synthetic enzymes
(Handa and Hakomori, 2017). Nonetheless, not all of the diversity in SL
production is explained by variations in gene expression (Nairn et al.,
2012). Thus, other factors acting at the post-transcriptional level aﬀect
SL production, which include speciﬁc conformations in the spatial ar-
rangement of the SL synthetic machinery and in SL traﬃcking (Yamaji
et al., 2008). Moreover, the production of the same bioactive SLs at
diﬀerent subcellular locations triggers speciﬁc cellular responses due to
the distinctive subcellular distribution of SL signalling targets empha-
sizing the importance of a space resolved analysis while studying SL
biology (Hannun and Obeid, 2011).
2.1. Localization of the SL synthetic machinery
The localization of enzymatic activities to the sub-cellular com-
partments was traditionally evaluated by sub-cellular fractionation
followed by assays for their activity (De Duve, 1965). In subcellular
fractionation approaches cells are homogenized and organelles are se-
parated due to their diﬀerent physical properties by the use of diﬀer-
ential centrifugation and density gradients. Individual fractions are
then tested for enzymatic activities or for immunoreactivity of anti-
bodies recognizing speciﬁc antigens (De Duve, 1965). While this
method is indeed powerful, the spatial resolution obtained is limited
and it was soon superseded by immunolocalization coupled to micro-
scopy. Immunohistochemistry and immunoﬂuorescence microscopy
have revolutionised our understanding of subcellular organization of
the cellular compartments. These coupled to electron microscopy, with
its unparalleled resolution and contextual information, have provided
most of the information about the organization of the sub-cellular
compartments and the localization of speciﬁc protein and metabolites
including those involved in SL biosynthesis.
2.1.1. Ceramide synthesis
As mentioned earlier, the production of Cer starts with the SPT
activity catalysed by the SPTLC genes. The SPT activity was localized to
the ER by subcellular fractionation assays, which showed that close to
98% of the SPT activity co-segregated with the ER fraction (Mandon
et al., 1992). Further, catalytic activity was also shown to be restricted
to the cytosolic side of the ER membrane, by protease sensitivity assays
using intact ER fractions (Mandon et al., 1992). While the assays de-
scribed above are robust, it is nevertheless possible that the measured
activity in the ER is due to the inability of the in vitro assay conditions to
measure SPT activity in other cellular fractions. This uncertainty was
overcome by immunolocalization assays using tagged versions of the
enzyme as well as by immunolocalizing endogenous proteins. Im-
munoﬂuorescence staining of tagged versions of SPTLC1 localized the
protein to ER in concordance with the fractionation assays, while the
localization of the endogenous protein showed that the protein also
localized to the nucleus and focal adhesions (Wei et al., 2009). While
these observed secondary localizations could be an artefact produced
by the antibody used, biochemical and functional studies that followed
have shown that this may not be the case (Wei et al., 2009). Never-
theless, in the absence of appropriate controls and the fact that the
tagged versions are seen only in the ER in line with the fractionation
assays suggest that the most likely localization of the SPT enzymatic
activity is the ER.
The 3-ketodihydrosphingosine produced by SPT is further processed
sequentially by KSR and CerS whose catalytic activities were shown to
reside in the isolated ER fractions. Their activities were localised to the
cytosolic side of the ER membrane by assaying the protease sensitivity
of the enzyme in the case of KSR and the enzyme activity in the case of
CerS (Kihara and Igarashi, 2004; Pewzner-Jung et al., 2006). In addi-
tion, immunoﬂuorescence staining has also conﬁrmed their localization
to the ER (Kihara and Igarashi, 2004; Pewzner-Jung et al., 2006). While
in the case of KSR, an untagged enzyme was used to localize the pro-
tein, C-terminal epitope tagged versions of CerS (which includes 6
isoforms CERS1-6) were used for the localization studies ER (Kihara
and Igarashi, 2004; Pewzner-Jung et al., 2006). The agreement between
the immunolocalization and the subcellular fractionation studies
strengthens the conclusion that these enzymes do localise to the ER and
their biosynthetic activity takes place in this compartment.
The dihydroceramide produced by CerS activity is then desaturated
Fig. 1. Schematic representation of SL biosynthetic reactions:
In cyan are SL metabolites: Ser, Serine; Pal-CoA, Palmitoyl-CoA; dhCer, dihy-
droceramide; Cer, ceramide; Cer-1-P, cearmide-1-phosphate; SM; sphingo-
myelin; GalCer, galactosylceramide; SGalCer, sulfo- galactosylceramide; GM4,
NeuAc-GalCer; GlcCer, glucosylceramide; LacCer, lactosylceramide; GM3,
NeuAc-LacCer; GM2, GalNAc-GM3; GM1, Gal-GM2; GD3, NeuAc-GM3; GD2,
GalNAc-GD3; GD1, Gal-GD2; GA2, GalNAc-LacCer; GA1, Gal-GA2; Lc3, GlcNAc-
LacCer; Lc4, Gal-Lc3; Gb3, Gal-LacCer; Gb4; GalNAc-Gb3. In red are SL syn-
thetic enzymes: SPTLC, Serine palmitoyltransferase; KSR; 3-Ketosphingosine
Reductase; CerS, Ceramide synthase; DES; sphingolipid-delta-4-desaturase;
CERK; Ceramide kinase; CERT, Ceramide transfer protein: SMS1, sphingo-
myelin synthase 1; GalCerS, GalCer synthase; GAlCerST, GalCer sulfo-trans-
ferase; GCS, GlcCer synthase; LCS, LacCer synthase; GM3S; GM3 syntahse;
GM2S; GM2 synthase; GM1S, GM1 synthase; GD3S, GD3 synthase; LC3S, Lc3
synthase; Lc4S, Lc4 synthase; Gb3S, Gb3 synthase; Gb4S, Gb4 synthase.
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by dihydroceramide desaturases (DES1/2). The DES1/2 activities have
been localized to the ER and speciﬁcally to its cytosolic side using the
protease sensitivity assays described earlier (Michel and van Echten-
Deckert, 1997). The protein has also been colocalized with cytochrome
b5 an ER marker in tissue sections and it also requires the cytochrome
for its activity (Enomoto et al., 2006). Thus, given the similarity in the
results obtained by two very diﬀerent techniques the protein localizes
very likely to the ER. Altogether these data indicate that SPTLCs, KSR,
DES1-2, and CERS1-6 coexist at the ER and all have their active sites
oriented in a way to make the cytosolic leaﬂet of ER membrane a
conducive environment for de novo Cer synthesis.
2.2. Localization of the Cer processing machinery
Most of the ceramide produced in the ER is converted to SM at the
Golgi apparatus. A major portion of the SM biosynthesis depends on the
non-vesicular transport of the Cer from the ER to the Golgi by the
ceramide transfer protein, CERT. CERT has been localized to the Golgi
by ﬂuorescence microscopy (Hanada et al., 2003). It has an N-terminal
pleckstrin homology (PH) domain that is necessary for its targeting to
the Golgi by binding phosphatidyl inositol 4-phosphate [PtdIns(4)P], a
FFAT (two phenylalanine in an acidic tract) motif that binds the VAP
proteins in the ER and a C-terminal START domain that is involved in
lipid transfer. The presence of domains to bind both ER and the Golgi
suggests that the protein is likely localized to the ER - Golgi membrane
contact sites that are speciﬁc regions of close membrane apposition
where non-vesicular lipid exchange events take place (De Matteis and
Rega, 2015). Dynamics of ceramide transfer studied using ﬂuorescently
labelled ceramide (see below) has shown the ER to Golgi transport of
ceramide mediated by CERT happens in a time frame of minutes
(Hanada et al., 2003).
The Cer thus transported to the Golgi is ﬁrst spontaneously trans-
located to the Golgi lumen where it is then converted to SM by the Golgi
localized SMS. Activity assays had localized the SMS to the cis/medial
Golgi (Futerman et al., 1990; Jeckel et al., 1990) as well as to the ba-
solateral plasma membrane. To this end, the membrane sub-fractions
were analysed for their SMS activity as well as activity of the com-
partment markers including the Golgi enzymes mannosidase, N-acetyl
glucosamine transferase (GlcNacT), galactosyl transferase and sialyl
transferase. The Golgi localized fraction of the SMS activity coincided
with the fraction containing Mannosidase II and GlcNacT leading to the
conclusion that the enzyme is localized in the cis/medial Golgi
(Futerman et al., 1990). Molecular cloning studies then revealed that
the mammalian genome encodes two isoforms of the enzyme SMS1 and
SMS2 localised to the Golgi and the plasma membrane respectively
(Huitema et al., 2004). High-resolution EM studies with the tagged
version of the protein showed that SMS1 was mostly concentrated in
the trans-side of the Golgi with the peak observed in the penultimate
cisterna on the trans side (Halter et al., 2007). This study did not ex-
plicitly discuss the localization of the SMS1 to the TGN and treatment of
the transfected cells with brefeldin A was shown to redistribute the
protein back to the ER suggesting that the protein mainly localized to
the Golgi stacks and very little if any of the protein is found in the TGN.
Of note, SMS localization also depends on the cell type used for the
study with SMS activity present mostly in the Golgi stacks in ﬁbroblasts
while it is restricted to the TGN in neuronal cells (Sadeghlar et al.,
2000).
Of the rest of the Cer that is not converted to SM, most is converted
to glycosphingolipids (GSLs). The GSL biosynthetic machinery is mainly
localized to the Golgi apparatus. An exception is the GalCer Synthase
(GalCerS) that is localized to the ER as evidenced by immuno-
ﬂuorescence analysis of epitope tagged version of the enzyme (Sprong
et al., 1998). The activity assays on isolated subcellular fractions had
localized the enzymes to several compartments including ER, Golgi and
the plasma membrane. A later study had showed that the anomalous
localization of the GalCerS activity in Golgi was due to the activity of
GlcCer synthase (GCS) which can also accept UDP-Galactose as a sub-
strate in the absence of glucose (Sprong et al., 1998). The cloned Gal-
CerS was found to be a type I membrane protein with its catalytic
portion in the lumen of the ER as evidenced by protease sensitivity
assays (Sprong et al., 1998). The localization of the enzyme to ER and
the presence of its catalytic activity on the luminal side imply that the
ceramide synthesized in the cytosolic side of the membrane translocates
across the membrane in order to accesses the catalytic domain. Further,
studies have shown that GalCerS interacts with galactose transporter
UGT1 to retain the transporter partially in the ER that in turn provides
the UDP-galactose necessary for the reaction (Sprong et al., 2003).
Unlike GalCerS which is a type I membrane protein of the ER, most
other ceramide processing machinery are localized to the Golgi and are
either type II membrane proteins or multi-transmembrane proteins like
GCS and SMS1. Among the GSL biosynthetic pathway, the ﬁrst enzyme,
the GCS has been localized to the Golgi (Coste et al., 1985). Experi-
ments on the localization of GCS enzymatic activity have suggested two
diﬀerent localizations. One study localized the activity to the cis-side of
the Golgi and a pre-Golgi compartment (Futerman and Pagano, 1991),
while another study showed a predominant localization only to the
Golgi apparatus but an equal distribution between the cis/medial and
trans-Golgi (Jeckel et al., 1992). Localization of the endogenous GCS in
Drosophila localized the protein both to the Golgi apparatus and the ER
(Kohyama-Koganeya et al., 2004). Expression of a tagged version of the
enzyme localized it to the Golgi and a quantitative immuno-EM of this
protein showed that it is distributed across the Golgi stack with a peak
in the trans-side, but unlike SMS1 a substantial portion of the enzyme
was also present in the cis-side of the Golgi (Halter et al., 2007). Thus,
both the activity based and the immunolocalization based assays (albeit
with a tagged construct) have shown that the protein is localized mostly
to the Golgi, where it is distributed across the stack with a slight pre-
ference for the cis-medial portion of the stack.
GCS active site is oriented towards the cytosolic membrane leaﬂet
(Jeckel et al., 1992) while LacCer synthesis and subsequent GSL syn-
thetic reactions are conﬁned to the luminal membrane side of the Golgi
complex (Burger et al., 1996). Moreover, diﬀerently from Cer, GlcCer
shows a remarkably low rate of spontaneous transbilayer movement in
model membranes, which implies the existence of an active mechanism
for the translocation of GlcCer from the cytosolic to the luminal
membrane for its processing (Buton et al., 2002). Both ER and Golgi
membranes have been found to rapidly translocate GlcCer to their
lumen in in vitro reconstitution assays in a saturable and protein-
mediated process (Buton et al., 2002; Chalat et al., 2012). The identity
of the GlcCer translocating protein is still largely elusive and the pos-
sibility that multiple factors contribute to GlcCer translocation at dif-
ferent cellular locations with diﬀerent metabolic outcomes has been
proposed (De Rosa et al., 2004).
The next enzyme in the GSL biosynthetic pathway is the LCS. The
LCS activity had been localized to the lumen of the Golgi apparatus
using protease sensitivity assays coupled to sub-cellular fractionation,
though its sub-Golgi localization was not worked out (Lannert et al.,
1994). Molecular cloning studies had shown that there are at least two
enzymes encoding the LCS activity B4GALT5 and B4GALT6. Studies
using mice and cell lines demonstrated that B4GALT5 is the main LCS in
most tissues (Tokuda et al., 2013) while B4GALT6 contributes 40% of
LacCer production in the brain (Yoshihara et al., 2018). The localiza-
tion of the B4GALT5 using quantitative cryo-immunoEM demonstrated
that the protein is localized all over the Golgi with a predominant
concentration in the trans-side (Halter et al., 2007). Though this study
had not examined its localization to the TGN, another study using semi-
quantitative immuno EM methods had demonstrated the localization of
B4GALT5 also the TGN (D’Angelo et al., 2013b).
The LacCer synthesized by LCS action can undergo at least 3 mu-
tually exclusive pathways of processing. The initiating enzymes of all
three pathways have been localized to the Golgi apparatus by activity-
based assays (Lannert et al., 1998). The ﬁrst is the globoside pathway,
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where Gb3 synthase (Gb3S) adds a galactose to initiate the production
of the globo series of GSLs. The biosynthesis of Gb3 by Gb3S is pro-
moted by the non-vesicular transport of GlcCer by FAPP2 (D’Angelo
et al., 2007) to a likely complex containing Gb3S and LCS. FAPP2 has a
glycolipid transfer domain through which it picks up GlcCer from the
cytosolic side of the Golgi apparatus and transfers it to the TGN where
the LCS and Gb3S are localized. Immunoelectron microscopy with a
tagged version of Gb3S showed that is predominantly present in the
TGN and as expected from a TGN localized protein the synthesis of Gb3
is sensitive to BFA (D’Angelo et al., 2013b). FAPP2 recognizes the trans-
Golgi through its PH domain that binds PtdIns(4)P. Immunoelectron
microscopy-based localization studies have shown that at steady state
FAPP2 localizes mainly to trans-side of the Golgi and TGN (D’Angelo
et al., 2013b). Its association with the cis-side of the Golgi to bind
GlcCer for delivery to the trans-Golgi probably depends on the ability of
the protein to bind ARF through its PH domain (D’Angelo et al., 2013b).
The second arm of the GSL biosynthetic pathway is the lacto/neo-
lacto series of GSLs. Lc3 synthase (Lc3S) adds a N-acetylgalactosamine
to start this series of GSLs (Henion et al., 2001). While the Lc3S is ex-
pected to be localized to the trans-side of the Golgi its precise intra-
Golgi localization is yet be to be explored in detail. The ﬁnal arm of the
GSL biosynthetic pathway is the ganglioside series characterized by the
presence of sialic acid residues. GM3 synthase (GM3S) adds a sialic acid
to start the ganglio series of GSLs. While GM3S is localized to the Golgi
apparatus it was not found in the TGN but showed a predominant lo-
calization to the trans-side of the Golgi apparatus (D’Angelo et al.,
2013b) and GM3 production is not sensitive to BFA (D’Angelo et al.,
2013b). GM3 thus produced is processed further by other enzymes in-
cluding GM2/GD2 synthase and others that are mainly localized to the
TGN (Giraudo et al., 1999).
A minor fraction of the ceramide is also phosphorylated by Cer
Kinase (CERK) to form Cer-1-phosphate (Cer1P) that has important
roles including the regulation of proliferation and apoptosis (Gomez-
Munoz, 2006). CERK localization has been controversial with published
reports that support its localization in the plasma membrane, endosome
like structures as well as Golgi apparatus (Lamour et al., 2007; Rovina
et al., 2009; Van Overloop et al., 2006). All of these studies had used
tagged versions of the protein and diﬀerent cell lines for these studies.
Whether the localization depends on the cell lines used for the study or
the presence of the tag that might diﬀerentially aﬀect localization is not
clear. Localization of the endogenous protein may help resolve this
issue. Further, the Cer1P produced by CERK is transported to the
plasma membrane by the Cer1P transfer protein (CPTP) whose action
reduces the Cer1P levels in the Golgi where cytosolic phospholipase A2
alpha acts on it to initiate the eicasonoid biosynthetic pathway
(Simanshu et al., 2013). The CPTP was localized to the TGN and en-
dosomes by immunoﬂuorescence analysis (Simanshu et al., 2013) and
the reduction in CPTP levels leads to an accumulation of Cer1P in TGN
suggesting that Cer1P is likely to be produced by the Golgi localized
CERK.
Finally, a fraction of Cer produced by the CerSes localized to the ER
can also be converted to acyl ceramide and stored in the lipid droplets.
This reaction is catalyzed by the diacylglycerol acyltransferase 2
(DGAT2) and the acyl chain for the reaction is supplied by fattyacyl
CoA synthase 5. These two enzymes interact with CerS in the ER and
are also found in the lipid droplets as evidenced by IF microscopy
(Senkal et al., 2017). The data about the localization of the SL bio-
synthetic system discussed here is depicted as a scheme in Fig. 2.
3. Dynamics of the SL biosynthetic machinery
An important aspect in the study of SL biosynthesis relates to the
dynamics of the system. Protein dynamics are usually analysed by
transfecting protein of interest tagged with a ﬂuorescent protein fol-
lowed by video microscopy (Lippincott-Schwartz et al., 2001). Fluor-
escence bleaching or photoconversion (change in ﬂuorescence
excitation/emission properties of a ﬂuorophore) obtained by the use of
high power laser sources allow the precise assessment of the dynamic
behaviours of the molecules of interest. For instance, the movement of
molecules within one compartment or among diﬀerent compartments
can be approached by Fluorescence recovery after photobleaching
(FRAP). In this method, a high intensity laser is focused on a small area
of the cell or an organelle of interest so as to bleach the ﬂuorophores
present in the area. The recovery of ﬂuorescence in this area due to the
movement of the ﬂuorophores from other regions of the cell is mon-
itored by video microscopy. The dynamics of the GSL biosynthetic en-
zymes (mostly involved in ganglioside synthesis) in the Golgi apparatus
and their cycling between diﬀerent compartment of the secretory
pathway was analysed by FRAP (Giraudo and Maccioni, 2003b). These
studies have shown that these enzymes do recycle through the ER with
kinetics comparable to that of the other glycosylation enzymes ex-
amined (Giraudo and Maccioni, 2003a). Further studies are needed to
examine their transport across the secretory pathway, the dynamics of
their recycling and role of the transport machinery in this process.
The FRAP analysis is easy to perform, but the ensuing analysis of
kinetics is complicated by the fact the measured ﬂuorescence recovery
is a combined eﬀect of both ﬂuorophore entry into as well as its exit out
of the bleached area. While in most cases involving a homogenous
compartment, the rates are the same, in speciﬁc cases it may not be so.
In these cases, to obtain the precise measure of the rates, FRAP is
usually combined with another technique called ﬂuorescence loss in
photobleaching (FLIP). In this analysis, all regions of the cell except the
region of interest is continuously bleached while monitoring the
ﬂuorescence levels in the region of interest. This method provides the
precise description of the kinetics of ﬂuorescence loss from the region of
Fig. 2. Schematic representation of the intracellular distribution of the SL
biosynthetic system.
SL metabolites (in cyan) and SL synthetic enzymes/ tranfer proteins (in red) are
represented according to their reported subcellular distribution. En, endosomal
system; GC, Golgi complex; ER, endoplasmic reticulum; LD, lipid droplet. The
yellow shaded area represents ER-Golgi membrane contact sites.
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interest or a measure of the kinetics of the ﬂuorophore exit from the
compartment or region of interest (McNally, 2008).
To date there have been limited attempts to study on the dynamics
of the SL biosynthetic system. This kind of approach would likely
produce interesting information especially if applied to the study of the
two lipid transfer proteins – CERT and FAPP2.
As discussed above CERT and FAPP2 pick-up their lipid cargoes
from the cytosolic leaﬂet of ER and cis-Golgi membranes respectively
subtracting them from the membrane traﬃcking stream to deliver them
directly to distal Golgi thus bypassing the intervening sub-compart-
ments (D’Angelo et al., 2013a; Hannun and Obeid, 2018). Both CERT
and FAPP2 mediated non-vesicular lipid transfer activities have been
proposed to convey SL substrates to an alternative metabolic fate to that
favoured by vesicular transport (D’Angelo et al., 2013b; Hanada et al.,
2003). Thus CERT by delivering Cer to the trans-Golgi makes it avail-
able to SMS1 and CERK for SM and Cer1P syntheses while FAPP2 de-
livers GlcCer to the TGN to favour the production of globo-series GSLs
that is initiated by the TGN localized Gb3S enzyme, while bypassing the
medial Golgi compartment where GM3S, the ﬁrst enzyme involved in
ganglio-series GSL synthesis resides (D’Angelo et al., 2013b). In
agreement with this model changes in the lipid transfer activities of
CERT and FAPP2 result in changes in the relative amounts of the dif-
ferent SL produced along the biosynthetic pathway. Moreover, the
static localization of CERT is inﬂuenced by phosphorylation (Yamaji
et al., 2008) and that of FAPP2 by its apo or lipid bound states
(D’Angelo et al., 2013b) suggesting that these parameters control their
dynamical association with cell membranes (Fig. 3).
Information is available on the dynamics of the related cholesterol
transfer protein OSBP (oxysterol binding protein). OSBP dynamics as
measured by FRAP assays indicated that the protein is highly mobile
(with a complete turnover observed within a minute and almost 80% of
the protein being mobile) in the absence of cholesterol, while the pre-
sence of cholesterol decreases the fraction of mobile protein (Mesmin
et al., 2013).
4. Supra-molecular complexes
A further layer of organization in the SL synthetic system deals with
the establishment and functioning of multi-enzymatic complexes.
Complex formation involving the SL synthetic enzymes promotes sub-
strate channelling and makes SL processing reactions more eﬃcient
(Spessott et al., 2012). Protein-protein interactions are often studied
using biochemical methods including co-puriﬁcation, size exclusion
chromatography, surface plasmon resonance, or acrylamide gel elec-
trophoresis (Phizicky and Fields, 1995). More recently imaging-based
methods have been developed to study protein complexes formation
that rely on ﬂuorescence measurements (Ciruela, 2008). Here, the in-
teraction between two proteins is translated into a ﬂuorescence signal
that can be monitored by microscopy that provides the additional in-
formation about the location where the interaction takes place.
Bimolecular interactions are studied by split-ﬂuorescent protein
technique where in the ﬂuorescent protein molecule is divided into
Fig. 3. Localization of SL biosynthetic machinery and
dynamics of ceramide transport.
a. Immunoﬂuorescence staining of hemagglutinin peptide
(HA) -tagged SMS1 and HA-tagged LCS using anti-HA
antibodies (green) demonstrates their localization to a
perinuclear structure (nucleus stained with DAPI in blue)
typical of Golgi apparatus. b. Immunogold labelling of
SMS1-HA and LCS-HA using colloidal gold tagged probes.
The HA-tagged proteins are indicated by green arrow
heads (10 nm gold for SMS1-HA and 15 nm gold for LCS-
HA) while a cis-Golgi marker GM130 is indicated with red
arrows (either 10 nm or 15 nm gold). As can be clearly
seen here both SMS1-HA and LCS-HA are localized to the
pole opposite GM130 suggesting trans-Golgi localization
of these proteins. c. HeLa cells were incubated with
BODIPY-labelled ceramide at 4 °C when it accumulates in
the ER as indicated by a diﬀuse staining and exclusion
from the nuclear area (0min). The shift to 37 °C leads to
very quick transport of ceramide from the ER and con-
centration in the peri-nuclear structure (Golgi apparatus).
The imaging of the transport of this ﬂuorescently labelled
ceramide was done by video microscopy and selected
frames from this movie are shown with corresponding
time after the shift to 37°C.
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two halves and these halves are tagged to two proteins that are being
tested for their interaction. For instance, the yellow ﬂuorescent protein
(YFP) molecule can be divided into the N-terminal half containing the
residues 1–173 and the C-terminal half containing the residues 155-
238. If the proteins to which they are tagged interact the two halves of
the YFP protein are brought together restoring a functional ﬂuorescent
protein that can be imaged (Kodama and Hu, 2013).
While this method is qualitative and at best semi-quantitative, a
quantitative measure of protein-protein interaction can be obtained
using ﬂuorescence resonance energy transfer (FRET). FRET involves
non-radiative energy transfer between two ﬂuorophores by dipole-di-
pole coupling and this transfer is inversely proportional to the distance
between the ﬂuorophores (as sixth power of the distance, so it rapidly
reduces!). In simpler terms, when two appropriate ﬂuorophores are
brought together, the activation of the donor ﬂuorophore leads to the
non-radiative energy transfer to the acceptor ﬂuorophore such that it
becomes excited. The emission from the acceptor ﬂuorophore can be
quantitated as a measure of protein-protein interaction (Pietraszewska-
Bogiel and Gadella, 2011; Shimozono and Miyawaki, 2008).
The FRET technique was used to study complex formation between
glycosphingolipid biosynthetic enzymes in the Golgi (Bieberich et al.,
2002; Ferrari et al., 2012). Studies based on split GFP and FRET mea-
surements have shown that the enzymes involved in consecutive reac-
tions in the SL synthetic pathway at the Golgi complex physically in-
teract to form multi-enzymatic complexes able to direct SL ﬂuxes
towards speciﬁc metabolic directions. Thus LCS, GM3S and GD3S form
a complex at medial trans Golgi able to mediate the direct conversion of
GlcCer to GD3 (Spessott et al., 2012); GM2S can interact with GM1S at
the TGN leading to GM3 conversion to GM1 (Giraudo et al., 2001) or
with GD3S leading to the conversion of GM3 to GD2 (Bieberich et al.,
2002) and similarly, LCS and Gb3S synthase have been suggested to
interact to yield Gb3 production from GlcCer. Importantly the compo-
sition of such multi-enzymatic complexes has been suggested to inﬂu-
ence their sub-Golgi localization thus demonstrating an inherent ca-
pacity of the biosynthetic system to adapt itself to cellular needs and
intercept diﬀerent substrate ﬂuxes (Uliana et al., 2006).
4.1. Visualizing the SLs and their dynamics
While studying the biosynthetic machinery is important to under-
stand the processes involved in biosynthesis, the direct visualization of
the substrates and products of these enzymatic reactions provides in-
sights into how the metabolites are handled by these machineries.
Visualizing SLs has been a challenge since any addition of ﬂuorophores
to these lipids has a high probability of changing their physic/chemical
nature and hence the results from these studies have to considered with
certain reservation. Nevertheless, several chemical SL probes have been
developed that have helped visualize the transport of these lipids and
their metabolism. These chemical SL probes rely on the use of chemi-
cally modiﬁed SLs where they are functionalized with a label that can
be detected by imaging techniques.
Fluorescently labelled SLs have been produced since the early
1980s that can be incorporated in cell membranes and followed by
conventional and live microscopy (or, following photo-conversion by
electron microscopy) along the endocytic and biosynthetic pathways
(Koval and Pagano, 1989, 1990; Lipsky and Pagano, 1983). Fluorescent
SLs are obtained by substituting the naturally occurring fatty acid with
a short ﬂuorescent one. A ﬁrst generation of ﬂuorescent SL probes was
based on 7-nitrobenz-2-oxa-1, 3-diazole (NBD)-labelled fatty acids
(Lipsky and Pagano, 1983, 1985a; Lipsky and Pagano, 1985b) and their
use allowed to reveal the compartmentalized nature of SL biosynthetic
pathway (Pagano and Sleight, 1985) i.e. the NBD labelled ceramides
ﬁrst label the ER, from where they are transported actively to the Golgi
apparatus and then to the plasma membrane.
Nonetheless the low ﬂuorescence yield and the relatively high hy-
drophilic nature of NBD that makes it to loop back to the membrane/
water interface, which translates into a short residence time of NBD-SLs
in lipid bilayers and this has cast doubts about their ability to re-
capitulate the behaviour of their non-labelled counterparts. In the
1990s, a second generation of ﬂuorescent SL probes based on boron
dipyrromethene diﬂuoride (BODIPY) was obtained (Pagano et al.,
1991, 2000) where their properties were more similar to that of natural
SLs. BODIPY-SLs have been instrumental in the understanding of non-
vesicular SL transport to and through the Golgi and for the study of
membrane microdomains due to the property of BODIPY to undergo a
concentration-dependent monomer-excimer ﬂuorescence shift (Marks
et al., 2008). Dynamics of Cer transport to the Golgi complex have been
studied by the use of ﬂuorescently labelled Cer analogues and were
found to be fast and dependent on the presence of CERT (Hanada et al.,
2003). A newer development in the production of SL probes for cellular
imaging is the use of click chemistry. Click chemistry allows the de-
tection of compounds containing azido groups or terminal alkynes that
can be visualized by microscopy after a chemical reaction with a
ﬂuorophore. Clickable SL analogues have been used recently for the
super resolution imaging of SLs in live cells (Erdmann et al., 2014).
A parallel approach to SL imaging is that involving aﬃnity probes
that have been developed for the visualisation of endogenous SL. These
probes consist either of proteins or protein domains with high binding
aﬃnity and speciﬁcity for a given SL or of antibodies recognizing
speciﬁc SL epitopes. Two main classes of aﬃnity probes have been
employed for SL imaging: these are toxins and anti-SL antibodies.
4.1.1. SL binding toxins
Being components of the luminal leaﬂet of the eukaryotic plasma
membranes some SLs are exposed to the extracellular environment and
several pathogens have evolved strategies to either infect or intoxicate
cells by using plasma membrane SLs as their targets. Speciﬁcally, some
SL-targeting toxins are equipped with suﬃcient aﬃnity and speciﬁcity
for individual SLs to be used as aﬃnity probes for SL visualization.
These include bacterial toxins such as Shiga and Cholera toxins
(Heyningen, 1974; Jacewicz et al., 1986) or toxins derived from me-
tazoa such as Lysenin and Equinatoxin II (Bonev et al., 2003; Yamaji
et al., 1998).
Lysenin (Yamaji et al., 1998) is a 33-kDa (297 aa) protein produced
by the earthworm Eisenia foetida that strongly binds SM and induces cell
death by forming pores upon oligomerisation at the plasma membrane
(Bokori-Brown et al., 2016; Yilmaz et al., 2018). Each lysenin monomer
binds ﬁve to six SM molecules preferentially when present in clusters in
the membranes. The C-terminus of lysenin is essential for binding to SM
while its N-terminal part is required for oligomerisation, thus a non-
toxic C-terminal lysenin fragment has been isolated that maintains SM
binding activity and is referred to as NT-lysenin. Both natural and NT-
lysenin have been employed to visualize SM by ﬂuorescence and elec-
tron microscopy (Kishimoto et al., 2016) while NT-lysenin, due to its
lack of toxicity, has been used to follow SM dynamics in living cells by
video microscopy (Carquin et al., 2014).
Also Equinatoxin II (EqtII), a 179-aa pore-forming toxin produced
by sea anemones, (Kishimoto et al., 2016) binds speciﬁcally to SM.
Nonetheless, EqtII preferentially decorates liquid disordered domains in
monolayers containing SM suggesting that diﬀerently from lysenin,
EqtII recognizes SM when in a ‘dispersed’ conformation (Kishimoto
et al., 2016). GFP-tagged EqtII (EqtII-GFP) has been used as an SM
probe both added exogenously to intact or permeabilised cells or as an
intracellularly (and luminally) expressed protein (Deng et al., 2016).
Depending on the mode of use EqtII-GFP has been found to decorate
speciﬁc PM domains, the endosomal compartment and the Golgi com-
plex (Kishimoto et al., 2016). Due to their diﬀerent aﬃnities to packed
and dispersed SM, lysenin and EqtII-GFP decorate mutually exclusive
SM pools in model membranes and in cells thus their combined use is
required to reveal the overall cellular SM distribution (Kishimoto et al.,
2016).
Shiga toxin is a bacterial toxin produced by Shighella dysenteriae
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and by some serotypes of Escherichia coli that causes bloody diarrhoea
in humans (Melton-Celsa, 2014). Shiga toxin is an AB5 toxin consisting
of a single A subunit associated with a pentamer of identical B subunits.
While the A subunit is responsible for cell toxicity by blocking protein
synthesis, the B pentamer binds to the GSL Gb3 in host cell membranes
(Johannes, 2017; Melton-Celsa, 2014) to mediate Shiga toxin en-
docytosis. Each Shiga toxin B subunit intercepts 2–3 Gb3 molecules
resulting in the high aﬃnity binding of the pentamer to Gb3 rich
membranes (Melton-Celsa, 2014). Shiga toxin B has been used to vi-
sualize Gb3 distribution in tissues by ﬂuorescence and histochemistry
approaches and on cells to evaluate Gb3 levels on cell membranes
(D’Angelo et al., 2013b).
Also, Cholera toxin produced by Vibrio cholerae that causes massive
secretory diarrhoea in humans, is a AB5 toxin (Wernick et al., 2010). As
in the case of Shiga toxin, the A subunit is responsible for toxicity as it
ADP-ribosylates the Gs alpha subunit of trimeric G proteins and forces it
to a constitutively GTP-bound activated form (Wernick et al., 2010).
The pentameric B subunit of Cholera toxin is instead responsible for the
binding to cell membranes and for toxin endocytosis thanks to its
binding to the GSL GM1. Due to its aﬃnity for GM1, Cholera toxin B
subunit has been used in a variety of imaging approaches to visualize
GM1 on cell membranes similar to Shiga toxin B subunit (D’Angelo
et al., 2013b).
4.1.2. Anti-SL antibodies
Antibodies recognizing diﬀerent SLs have been produced over the
years, some of which have been used for lipid immuno-localization.
These include anti-Cer (Cowart et al., 2002), anti-GlcCer (Brade et al.,
2000), anti LacCer (Iwabuchi et al., 2015; Symington et al., 1987), anti-
GM3 (Kotani et al., 1992), anti-Gb3 (Kotani et al., 1992), and have been
used for immunoﬂuorescence and immunoEM studies on cells and tis-
sues and in cytoﬂuorimetric studies. Nevertheless, while aﬃnity probes
have provided valuable information about the tissue and cellular dis-
tribution of SLs they have limitations since their ability to bind SLs is
often inﬂuenced by the accessibility of SLs in membranes and that most
of them require elaborate ﬁxation procedures to preserve the SL loca-
lization prior to detection.
A recent advance in visualization of the SLs is the development of
label free methods based on mass spectrometry. Both the use of aﬃnity
and chemical probes for the visualisation of SLs have limitations due to
the fact that SLs when chemically modiﬁed or engaged by toxins or
antibodies behave diﬀerently than their natural counterparts. This has
stimulated interest in the development of label-free (or minimal label-
ling) imaging strategies for SLs. One promising technology in this re-
spect is Imaging Mass Spectrometry (IMS). IMS is a MS-based tech-
nique that enables the detection metabolites in a space resolved fashion
and the generation distribution maps of a wide range of molecules, in
the same specimen, without the need for invasive labelling and without
altering the morphology of the tissue (Sugiura and Setou, 2010).
Among the diﬀerent IMS methods available, two have found applica-
tion in SL research - nanoscale secondary ion mass spectrometry [na-
noSIMS] and Matrix-assisted laser desorption/ ionization [MALDI]-IMS.
NanoSIMS enables the visualization of metabolically incorporated
stable-isotope labelled SLs in membranes with a space resolution<
50 nm (Klitzing et al., 2013). In a nanoSIMS experiment a cesium or
oxygen ion beam is scanned over the sample surface, molecules within
the beam’s focal volume are fragmented and the charged secondary ions
ejected from the sample surface are analysed by a mass spectrometer
(Nunez et al., 2017). NanoSIMS allows the assessment of the nanoscopic
distribution of the diﬀerent isotope-containing ions based on their
precise mass-to-charge ratios (Nunez et al., 2017). A key advantage of
nanoSIMS imaging is that it does not require using SLs modiﬁed with
bulky ﬂuorescent tags. Stable isotopes have indeed little or no eﬀect on
the biological properties of SL and a large variety of stable iso-
tope–labeled lipids are available from commercial vendors. The main
disadvantages of nanoSIMS lay in the facts that (i) it requires some
preconceived knowledge of the sample and allows the assessment of
only the labelled compounds and (ii) it requires invasive sample ma-
nipulations including ﬁxation and dehydration and analysis under high
vacuum.
Some of these limitations are overcome by MALDI-IMS. In a typical
MALDI-IMS experiment, a frozen tissue sample is sectioned and
mounted on a target plate. Subsequently, the tissue is coated with a
homogenous layer of an organic matrix solution, placed in an ionization
chamber and analysed. There, a laser beam ‘scans’ a speciﬁc area of the
sample and collects a mass spectrum for each coordinate. The ﬁnal
distribution image of a speciﬁc ion is then generated by dedicated
software that plots the intensity of that ion against the x-y coordinate.
MALDI-IMS is completely label-free and it has been optimized to work
at atmospheric pressure with minimal sample manipulation (Yalcin and
de la Monte, 2015). The main disadvantage of MALDI-IMS is in its low
spatial resolution (> 1 μm) that does not yet allow subcellular studies
of lipid distribution.
5. Future directions
A signiﬁcant body of knowledge has been accumulated on the lo-
calization and dynamics of both the SL biosynthetic machinery and the
substrates/products themselves. Nevertheless, there are some glaring
lacunae that need to be ﬁlled and also recent advances in molecular
biology and imaging that need to be incorporated in the future studies
to understand the system better. Some of these future directions are
summarized below:
a As mentioned earlier, the dynamics of the sphingolipid machinery
is an almost untouched area. Study of dynamics of glycosylation
enzymes started nearly 20 years ago and has yielded several insights
into the cell biology of the Golgi organization (Cole et al., 1996). We
can predict that the study of dynamics of the SL biosynthetic en-
zymes and products would provide insights into their organization,
the method of transport of the metabolites and quantitative test of
present models of sphingolipid biosynthesis based on the study dy-
namics of the biosynthetic machinery.
b Most of the SL biosynthetic enzymes are expressed in low copy
numbers in the cell and the need to study their dynamics and lo-
calization necessarily involves transfecting exogenous proteins that
sometimes far exceed the endogenous levels. This casts doubts on
the observed results. The recent development of CRISPR/Cas9
system that allows for genome editing so as to tag the endogenous
proteins provides the opportunity to study the localization and dy-
namics of the proteins expressed at the low endogenous levels and
under the regulatory controls that they are expected to have.
c The recent development of the Retention using selective hooks (RUSH)
system (Boncompain et al., 2012) provides an easy way to syn-
chronize the transport of several proteins along the secretory
pathway. Application of this system to the GSL biosynthetic
pathway will provide insights into the dynamics of the transport of
GSL biosynthetic enzymes and help in the identiﬁcation of the
molecular machinery involved in this process.
d The development of novel chemical probes to visualize the
sphingolipids is an active area of research and new developments
in the future can be expected to lead to probes that are easily de-
tectable and have physical-chemical properties similar to the en-
dogenous ones.
e The SL biosynthetic pathway, in most cases, is studied in isolation,
while it interacts extensively with the other lipid biosynthetic
pathways. A prominent example is the PtdIns(4)P dependent reg-
ulation of both cholesterol and ceramide transport at the ER-Golgi
contact sites. Thus, to study SL biosynthesis in the context of larger
lipid biosynthesis would provide insights into communication
channels between them and how they might be co-regulated to
maintain cellular homeostasis.
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f The accumulated knowledge on the localization of the diﬀerent
segments of SL synthetic machinery allows the drawing of a co-
herent model for the distributed SL biosynthesis under static con-
ditions. Whether and how this topological orgaziation is altered
under physiological or pathological conditions is currently not
known. Learning about instances where changes in enzymes loca-
lization or SL traﬃcking impact on SL metabolism will probably
reveal new important details in the organization of the SL synthetic
system.
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